# Prominent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypes

## TL;DR

The gut microbiome plays a key role in linking lifestyle factors like diet and exercise to heart and metabolic health.

## Contribution

A composite lifestyle score (QASD) was developed and shown to strongly influence gut microbiome composition and host metabolic phenotypes.

## Key findings

- Microbiome gene richness mediated 27.8% of the effect of the QASD score on insulin resistance marker HOMA-IR.
- 47 mediations were identified where microbial taxa mediated over 20% of the QASD score's effect on serum metabolites linked to insulin resistance.

## Abstract

Lifestyle factors influence both gut microbiome composition and host metabolism, yet their combined and mediating effects on host phenotypes remain poorly characterized in cardiometabolic populations. In 1,643 participants from the MetaCardis study, we developed a composite lifestyle score (QASD: dietary quality, physical activity, smoking, and diet diversity) that outperformed individual lifestyle variables in explaining microbial gene richness and exhibited a significant impact on the gut microbiome composition. While bidirectional pathways linking the QASD score, host phenotypes, and microbiome composition were assessed, causal inference-based mediation analyses indicated stronger effects when the microbiome was modeled as the mediator variable, particularly in relation to the insulin resistance-associated profile. Microbiome gene richness emerged as a key mediator explaining 27.8% of QASD score’s effect on the insulin resistance marker (HOMA-IR), while no significant mediation was observed on BMI. Extended mediation analyses on microbial species and serum metabolomics deconfounded for drug use and clinical profiles identified 47 mediations where microbial taxa mediated more than 20% of the effect of the QASD score on serum metabolites associated with insulin resistance. Notably, several Faecalibacterium lineages enriched in individuals with high QASD score played a significant mediatory role in increasing the serum biomarkers of microbiome diversity (as cinnamoylglycine or 3-phenylpropionate). Conversely, elevated levels of secondary bile acids in individuals with low QASD scores were strongly mediated by high levels of Clostridium bolteae. These findings highlight distinct and clinically relevant microbiome pathways linking lifestyle behaviors to cardiometabolic risks.

One sentence summary:

The gut microbiome mediates the impact of diet quality and diversity, physical activity and smoking status – combined in a composite lifestyle score – on cardiometabolic phenotypes.